Seres Therapeutics, Inc.
MCRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $31 | $128 | $163 | $180 |
| Short-Term Investments | $0 | $0 | $18 | $111 |
| Receivables | $5 | $0 | $0 | $0 |
| Inventory | $0 | $30 | $0 | $0 |
| Other Curr. Assets | $3 | $18 | $13 | $13 |
| Total Curr. Assets | $39 | $175 | $195 | $304 |
| Property Plant & Equip (Net) | $92 | $108 | $134 | $36 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $10 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $75 | $10 | $15 |
| Total NC Assets | $101 | $183 | $154 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $140 | $359 | $349 | $355 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $17 | $14 |
| Short-Term Debt | $9 | $6 | $4 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $8 | $4 | $17 |
| Other Curr. Liab. | $28 | $82 | $60 | $45 |
| Total Curr. Liab. | $41 | $99 | $86 | $82 |
| LT Debt | $83 | $193 | $159 | $43 |
| Deferred Rev, NC | $0 | $95 | $92 | $87 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $16 | $1 | $11 |
| Total NC Liab. | $85 | $305 | $252 | $141 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $92 | $97 | $112 | $25 |
| Total Liabilities | $126 | $403 | $338 | $223 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$978 | -$978 | -$865 | -$614 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $992 | $933 | $875 | $746 |
| Total Equity | $14 | -$45 | $11 | $132 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $140 | $359 | $349 | $355 |
| Net Debt | $61 | $71 | -$0 | -$131 |